Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway

Hsiao Mei Chao, Hong Xuan Huang, Po Hsiang Chang, Kuo Chang Tseng, Atsushi Miyajima, Edward Chern

研究成果: 雜誌貢獻文章

12 引文 (Scopus)

摘要

Y-box binding protein-1 (YB-1) is a pleiotropic molecule that binds DNA to regulate genes on a transcriptional level in the nucleus and binds RNA to modulate gene translation in the cytoplasm. In our previous studies, YB-1 was also characterized as a fetal hepatic protein that regulates the maturation of hepatocytes and is upregulated during liver regeneration. Moreover, YB-1 has been shown to be expressed in human hepatocellular carcinoma (HCC). However, the role of YB-1 in HCC remains unclear. Here, we aimed to characterize the role of YB-1 in HCC. Based on the results of loss-of-function in HCC and gain-of-function in mice liver using hydrodynamic gene delivery, YB-1 promoted hepatic cells proliferation in vitro and in vivo. YB-1 was also involved in HCC cell proliferation, migration, and drug-resistance. The results of extreme limiting dilution sphere forming analysis and cancer initiating cell marker analysis were also shown that YB-1 maintained HCC initiating cells population. YB-1 also induced the epithelial-mesenchymal transition and stemness-related gene expression. Knockdown of YB-1 suppressed the expression of Wnt ligands and β-catenin, impaired Wnt/β-catenin signaling pathway and reduced the numbers of HCC initiating cells. Moreover, YB-1 displayed nuclear localization particularly in the HCC initiating cells, the EpCAM+ cells or sphere cells. Our findings suggested that YB-1 was a key factor in HCC tumorigenesis and maintained the HCC initiating cell population.

原文英語
頁(從 - 到)2604-2616
頁數13
期刊Oncotarget
8
發行號2
DOIs
出版狀態已發佈 - 一月 1 2017

指紋

Y-Box-Binding Protein 1
Catenins
Wnt Signaling Pathway
Hepatocellular Carcinoma
Carcinogenesis
Hepatocytes
Cell Proliferation
Fetal Proteins
Genes
Liver Regeneration
Epithelial-Mesenchymal Transition
Liver
Hydrodynamics
Drug Resistance
Population
Cell Movement

ASJC Scopus subject areas

  • Oncology

引用此文

Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway. / Chao, Hsiao Mei; Huang, Hong Xuan; Chang, Po Hsiang; Tseng, Kuo Chang; Miyajima, Atsushi; Chern, Edward.

於: Oncotarget, 卷 8, 編號 2, 01.01.2017, p. 2604-2616.

研究成果: 雜誌貢獻文章

Chao, Hsiao Mei ; Huang, Hong Xuan ; Chang, Po Hsiang ; Tseng, Kuo Chang ; Miyajima, Atsushi ; Chern, Edward. / Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway. 於: Oncotarget. 2017 ; 卷 8, 編號 2. 頁 2604-2616.
@article{b43c8c0693a34dfe82c66383bfa09a49,
title = "Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway",
abstract = "Y-box binding protein-1 (YB-1) is a pleiotropic molecule that binds DNA to regulate genes on a transcriptional level in the nucleus and binds RNA to modulate gene translation in the cytoplasm. In our previous studies, YB-1 was also characterized as a fetal hepatic protein that regulates the maturation of hepatocytes and is upregulated during liver regeneration. Moreover, YB-1 has been shown to be expressed in human hepatocellular carcinoma (HCC). However, the role of YB-1 in HCC remains unclear. Here, we aimed to characterize the role of YB-1 in HCC. Based on the results of loss-of-function in HCC and gain-of-function in mice liver using hydrodynamic gene delivery, YB-1 promoted hepatic cells proliferation in vitro and in vivo. YB-1 was also involved in HCC cell proliferation, migration, and drug-resistance. The results of extreme limiting dilution sphere forming analysis and cancer initiating cell marker analysis were also shown that YB-1 maintained HCC initiating cells population. YB-1 also induced the epithelial-mesenchymal transition and stemness-related gene expression. Knockdown of YB-1 suppressed the expression of Wnt ligands and β-catenin, impaired Wnt/β-catenin signaling pathway and reduced the numbers of HCC initiating cells. Moreover, YB-1 displayed nuclear localization particularly in the HCC initiating cells, the EpCAM+ cells or sphere cells. Our findings suggested that YB-1 was a key factor in HCC tumorigenesis and maintained the HCC initiating cell population.",
keywords = "HCC, Stemness, Tumor-initiating cell, Wnt, Y-box binding protein 1",
author = "Chao, {Hsiao Mei} and Huang, {Hong Xuan} and Chang, {Po Hsiang} and Tseng, {Kuo Chang} and Atsushi Miyajima and Edward Chern",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.13733",
language = "English",
volume = "8",
pages = "2604--2616",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "2",

}

TY - JOUR

T1 - Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway

AU - Chao, Hsiao Mei

AU - Huang, Hong Xuan

AU - Chang, Po Hsiang

AU - Tseng, Kuo Chang

AU - Miyajima, Atsushi

AU - Chern, Edward

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Y-box binding protein-1 (YB-1) is a pleiotropic molecule that binds DNA to regulate genes on a transcriptional level in the nucleus and binds RNA to modulate gene translation in the cytoplasm. In our previous studies, YB-1 was also characterized as a fetal hepatic protein that regulates the maturation of hepatocytes and is upregulated during liver regeneration. Moreover, YB-1 has been shown to be expressed in human hepatocellular carcinoma (HCC). However, the role of YB-1 in HCC remains unclear. Here, we aimed to characterize the role of YB-1 in HCC. Based on the results of loss-of-function in HCC and gain-of-function in mice liver using hydrodynamic gene delivery, YB-1 promoted hepatic cells proliferation in vitro and in vivo. YB-1 was also involved in HCC cell proliferation, migration, and drug-resistance. The results of extreme limiting dilution sphere forming analysis and cancer initiating cell marker analysis were also shown that YB-1 maintained HCC initiating cells population. YB-1 also induced the epithelial-mesenchymal transition and stemness-related gene expression. Knockdown of YB-1 suppressed the expression of Wnt ligands and β-catenin, impaired Wnt/β-catenin signaling pathway and reduced the numbers of HCC initiating cells. Moreover, YB-1 displayed nuclear localization particularly in the HCC initiating cells, the EpCAM+ cells or sphere cells. Our findings suggested that YB-1 was a key factor in HCC tumorigenesis and maintained the HCC initiating cell population.

AB - Y-box binding protein-1 (YB-1) is a pleiotropic molecule that binds DNA to regulate genes on a transcriptional level in the nucleus and binds RNA to modulate gene translation in the cytoplasm. In our previous studies, YB-1 was also characterized as a fetal hepatic protein that regulates the maturation of hepatocytes and is upregulated during liver regeneration. Moreover, YB-1 has been shown to be expressed in human hepatocellular carcinoma (HCC). However, the role of YB-1 in HCC remains unclear. Here, we aimed to characterize the role of YB-1 in HCC. Based on the results of loss-of-function in HCC and gain-of-function in mice liver using hydrodynamic gene delivery, YB-1 promoted hepatic cells proliferation in vitro and in vivo. YB-1 was also involved in HCC cell proliferation, migration, and drug-resistance. The results of extreme limiting dilution sphere forming analysis and cancer initiating cell marker analysis were also shown that YB-1 maintained HCC initiating cells population. YB-1 also induced the epithelial-mesenchymal transition and stemness-related gene expression. Knockdown of YB-1 suppressed the expression of Wnt ligands and β-catenin, impaired Wnt/β-catenin signaling pathway and reduced the numbers of HCC initiating cells. Moreover, YB-1 displayed nuclear localization particularly in the HCC initiating cells, the EpCAM+ cells or sphere cells. Our findings suggested that YB-1 was a key factor in HCC tumorigenesis and maintained the HCC initiating cell population.

KW - HCC

KW - Stemness

KW - Tumor-initiating cell

KW - Wnt

KW - Y-box binding protein 1

UR - http://www.scopus.com/inward/record.url?scp=85009754312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009754312&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13733

DO - 10.18632/oncotarget.13733

M3 - Article

AN - SCOPUS:85009754312

VL - 8

SP - 2604

EP - 2616

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -